Amended Statement of Beneficial Ownership (3/a)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Niihara Yutaka	2. Date of Event Requiring Statement (MM/DD/YYYY) 7/17/2019	3. Issuer Name and Ticker or Trading Symbol Emmaus Life Sciences, Inc. [EMMA]
(Last)        (First)        (Middle) 21250 HAWTHORNE BLVD., SUITE 800	4. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                          ___X___ 10% Owner ___X___ Officer (give title below)        _____ Other (specify below) Chairman and CEO /
(Street) TORRANCE, CA 90503       (City)              (State)              (Zip)	5. If Amendment, Date Original Filed(MM/DD/YYYY) 7/29/2019	6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common stock, $0.001 par value	10163793	D (1)
Common stock, $0.001 par value	10501	I	By Soomi Niihara
Common stock, $0.001 par value	92794	I	By Hope International Hospice, Inc. (2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock option	4/2/2012	4/2/2022	Common stock	262536	$3.4281	D
Stock option	2/28/2013	2/28/2023	Common stock	525072	$3.4281	D
Stock option	5/10/2016	5/10/2026	Common stock	315043	$4.7613	D
Common stock purchase warrant	9/30/2016	5/9/2021	Common stock	1365189	$4.7612	D

Explanation of Responses:
(1)	Includes shares owned jointly with Soomi Niihara, Dr. Niihara's wife.
(2)	Hope International Hospice, Inc, is a California corporation of which Dr. Niihara and his wife are the sole shareholders and directors.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Niihara Yutaka 21250 HAWTHORNE BLVD. SUITE 800 TORRANCE, CA 90503	X	X	Chairman and CEO

Signatures
Yutaka Niihara, M.D., M.P.H.		9/9/2019
**Signature of Reporting Person		Date